L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own DNA

Ginkgo Bioworks Holdings Inc in the Q2 2026 filings. At least 2 of the 91 current managers on file reported a position, worth $59m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.

Managers holding
2
at least, of 91 current
Combined value
$59m
as reported
Opened
0
new this quarter
Added to
0
already held
Trimmed or sold out
0
0 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
Viking Global Investors LP
Long/short equity · $35.1bn book
$35m0.1%3,577,128+$14m0Held
Baillie Gifford & Co
Long-only · $110bn book
$24m0.0%2,391,649+$9.0m0Held

Ownership through time

At least 3 of the 95 managers whose filings are on file listed DNA in Q2 2026, against 5 in Q3 2024. 1 manager more than in Q1 2026: 1 listed it again.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
035Q3 2024: 55Q4 2024: 44Q1 2025: 4425Q2 2025: 44Q3 2025: 55Q4 2025: 44Q1 2026: 2226Q2 2026: 33
  • Q3 2024: 5
  • Q4 2024: 4
  • Q1 2025: 4
  • Q2 2025: 4
  • Q3 2025: 5
  • Q4 2025: 4
  • Q1 2026: 2
  • Q2 2026: 3
Their combined reported value
$0$52m$104mQ3 2024: $62m$62mQ4 2024: $72m$72mQ1 2025: $43m$43m25Q2 2025: $80m$80mQ3 2025: $104m$104mQ4 2025: $52m$52mQ1 2026: $37m$37m26Q2 2026: $61m$61m
  • Q3 2024: $62m
  • Q4 2024: $72m
  • Q1 2025: $43m
  • Q2 2025: $80m
  • Q3 2025: $104m
  • Q4 2025: $52m
  • Q1 2026: $37m
  • Q2 2026: $61m

Started in Q2 2026

No manager on file started a position.

Added to it

Cut it

No manager on file cut it.

Left it

No manager on file is shown leaving it.

ManagerValue over timeFirst listedLargestQ2 2026
Viking Global Investors LPQ3 2024$52m$35m
Baillie Gifford & CoQ3 2024$47m$24m
Caxton Associates LLPQ3 2024$1.9m$1.5m
Glenview Capital Management LLCQ3 2024$3.9mlast listed Q4 2025
PDT Partners LLCQ3 2024$2.2mlast listed Q3 2025

What DNA is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around DNA →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.